People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action

Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0–14 years: a population-based retrospective cohort study

(2022) Fanny Jansson Sigfrids et al.   Lancet Diabetes & Endocrinology

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation

(2022) Thomas R. Fleming et al.   Therapeutic Innovation & Regulatory Science

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

(2021) Hong Sun et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

(2020) George L. Bakris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk Factors for Kidney Disease in Type 1 Diabetes

(2019) Bruce A. Perkins et al.   DIABETES CARE

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

(2019) Daniël H. van Raalte et al.   DIABETES CARE

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study

(2016) I. H. de Boer et al.   Clinical Journal of the American Society of Nephrology

Endothelin and endothelin antagonists in chronic kidney disease

(2014) Donald E Kohan et al.   KIDNEY INTERNATIONAL